SCHEMBL23966871

SCHEMBL23966871

CC(O)(Cn1nc(Cc2nc3cc(OCC(F)F)c(Cl)cc3[nH]2)c2cc(C(N)=O)ccc2c1=O)N1CCOCC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR2 O95136 10/20 0.58
RHEB Q15382 1/20 0.34
GRM2 Q14416 1/20 0.33
F9 P00740 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.31
KDM4E B2RXH2 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
ALDH1A1 P00352 1/20 0.31
MEN1 O00255 1/20 0.31
USP2 O75604 1/20 0.31
MAPT P10636 1/20 0.31
KMT2A Q03164 1/20 0.31
HSD17B10 Q99714 1/20 0.31
JAK2 O60674 1/20 0.30
PIK3CD O00329 1/20 0.30
PIK3CA P42336 1/20 0.30
PIK3CB P42338 1/20 0.30
MGLL Q99685 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23908950 0.88 S1PR2 (0.70) S1PR2RHEBMEN1USP2MAPT
SCHEMBL23914869 0.78 S1PR2 (0.72) S1PR2RHEBMEN1KMT2APIK3CD
SCHEMBL23908734 0.77 S1PR2 (0.69) S1PR2RHEBUSP2
SCHEMBL23908755 0.76 S1PR2 (0.68) S1PR2RHEBALDH1A1MEN1KMT2A
SCHEMBL23908842 0.76 S1PR2 (0.79) S1PR2SMN1; SMN2KDM4EMEN1MAPT
SCHEMBL23908835 0.75 S1PR2 (0.66) S1PR2RHEBSMN1; SMN2KDM4ECYP3A4
SCHEMBL23908996 0.74 S1PR2 (0.67) S1PR2RHEBALDH1A1MEN1KMT2A
SCHEMBL23908918 0.74 S1PR2 (0.69) S1PR2RHEB
SCHEMBL23966552 0.74 S1PR2 (0.84) S1PR2RHEB
SCHEMBL23966848 0.73 S1PR2 (0.72) S1PR2RHEB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3649119-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS GALAPAGOS NV (BE) 2021-11-03 EP disclosed